DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)

Post-LOE

desmopressin acetate

Ferring Pharmaceuticals

ANDANASALSPRAY, METERED

Approved

Jan 2005

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) (desmopressin acetate) by Ferring Pharmaceuticals is 2 (v2) receptors, thereby increasing water re-absorption in the kidney, and hence reducing urine production. Approved for nephrogenic diabetes insipidus, central diabetes insipidus. First approved in 2005.

Drug data last refreshed 18h ago

Mechanism of Action

2 (V2) receptors, thereby increasing water re-absorption in the kidney, and hence reducing urine production. Desmopressin is a replacement hormone for antidiuretic hormone in the treatment of central diabetes insipidus. The change in structure of arginine vasopressin to desmopressin acetate…

Indications (2)

nephrogenic diabetes insipidus central diabetes insipidus

Worked on DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)

Mechanism of Action

Indications (2)

Clinical Trials (1)